Alibaba owns almost 9% of the Chinese social media influencer network, which has filed to go public in the US.

Genomic medicine developer Precision Biosciences plans to raise up to $100m in an upcoming IPO that could hand exits to Duke University and corporates Amgen, EMS and Baxter.

The genomic medicine developer plans to raise up to $100m in an upcoming IPO that could hand exits to Amgen Ventures, Brace Pharma Capital and Baxter Ventures.

Rakuten, General Motors and Alphabet own a combined 26% share of the ride hailing platform, which has filed to go public and which was valued at more than $15bn as of last June.

DataStax last raised funding in 2014 when Comcast Ventures backed its $106m series E round, and now the database technology developer is aiming for a $1bn valuation in its IPO.

Tencent-backed Futu has set its range at $10 to $12 and stands to raise a maximum of $150m, half of the $300m it had initially targeted.

Tiger Brokers, an online brokerage service backed by Xiaomi, has filed for a $150m initial public offering on Nasdaq.

Taikang and WuXi-backed CStone Pharmaceuticals has priced its shares near the middle of its proposed range to raise $285m in proceeds at a valuation of $1.5bn.

Rare disease diagnosis technology developer Centogene is gearing up for an IPO having spun out from Rostock in 2006 and raised $28.5m of equity funding in 2017.

Qualcomm-backed video conferencing software developer Zoom is aiming to go public in April and has filed confidentially with the US regulator.